Nanomaterials are present in a number of commercially available products but there are uncertainties as to whether the unique properties that support their commercial use may also pose potential health risks. Information is missing concerning the influence of nanomaterials on the overall reproductive outcome and transgenerational effects in animals and plants. To obtain this information, long-term studies would be required using animal models phylogenetically close to humans and exposure conditions that reflect realistic scenarios with regard to dosages and admission. The nanoreprotoxicology literature published to date is largely descriptive in nature regarding the effects of nanoparticles. The mechanisms, which determine particle reproduction compatibility, are mostly elusive at the moment. Thus, it is recommended that future research explore the interactions between nanomaterials and transgenerational matter on a molecular level. It would, for instance, be of major importance to understand the behaviour of nanoparticles inside the cells but also their genotoxic and epigenetic effects. Recent studies have shown that intravenous and/or intra-abdominal administration of nanoparticles to mice results in their accumulation in the cells of many tissues, including the brain and the testis, suggesting that they easily pass through the blood-brain and blood-testis barriers. In parallel embryo development after exposure to nanoparticles should be comparatively investigated. The majority of studies on embryo toxicology have concentrated on piscine embryos, mostly derived from zebrafish. Plants for human food as an important component of the ecosystem need also to be taken into account when evaluating transgenerational effects of engineered nanomaterials in crops.